Cue Biopharma (1UC0.MU) Q2 2026 Earnings

14MayConfirmed
Q2 2026
-2.83
-2.19
-1.56
-0.93

Details

Expected EPS
-2.82909
Actual EPS
-0.925884
Surprise EPS
1.9
Surprise Percent
+67.27%

Description

Cue Biopharma (1UC0.MU) has reported earnings of -0.925884 per share for Q2 2026.

0 Comments

Share your thoughts